64x Bio

64x Bio is discovering new mammalian cell lines to transform cell and gene therapy manufacturing. To develop and manufacture cell therapies, cell lines that are easy to manipulate, engineer and grow are required. 64x Bio is using their VectorSelect platform to generate highly optimized cell lines that meet the requirements for production of cell therapies. In particular, 64x Bio is enhancing the efficiency of cell lines to manufacture viral vectors that improve manufacturing capacity and reduce overall cost. This involves high-throughput genome engineering, screening technologies and 64x Bio’s proprietary genetic barcoding method that connects information of viral vector productivity back to the parent cell which produced it.

Jobs: